"The Food and Drug Administration (FDA) today issued a Certificate of Exemption for the SARS CoV-2 PCR Detection Kit," said the FDA in a statement released on March 9. The statement also explained how the technology was funded by the Department of Science & Technology (DOST).
"The kit will be used for field testing coupled with gene sequencing at the Philippine Genome Center," the FDA added.
"This will provide our laboratories with technological reinforcement to accommodate the growing number of patients to be tested and aid in early screening of positive cases," said the FDA. "Furthermore, this will provide greater access to a less costly diagnostic procedure."
On March 7, the Department of Health (DOH) raised its alert level to Code Red for COVID-19, after confirming the local transmission of the disease.